• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于控释载蛋白药物递送系统的聚合物微球的研制与表征

Development and characterization of polymeric microspheres for controlled release protein loaded drug delivery system.

作者信息

Ravi S, Peh K K, Darwis Yusrida, Murthy B Krishna, Singh T Raghu Raj, Mallikarjun C

机构信息

School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor, Pulau Penang, 11800, Malaysia.

出版信息

Indian J Pharm Sci. 2008 May-Jun;70(3):303-9. doi: 10.4103/0250-474X.42978.

DOI:10.4103/0250-474X.42978
PMID:20046737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2792511/
Abstract

The aim of the present work was to investigate the preparation of microspheres as potential drug carriers for proteins, intended for controlled release formulation. The hydrophilic bovine serum albumin was chosen as a model protein to be encapsulated within poly(D,L-lactide-co-glycolide) (50:50) microspheres using a w/o/w double emulsion solvent evaporation method. Different parameters influencing the particle size, entrapment efficiency and in vitro release profiles were investigated. The microspheres prepared with different molecular weight and hydrophilicity of poly(D,L-lactide-co-glycolide) polymers were non porous, smooth surfaced and spherical in structure under scanning electron microscope with a mean particle size ranging from 3.98 to 8.74 mum. The protein loading efficiency varied from 40 to 71% of the theoretical amount incorporated. The in vitro release profile of bovine serum albumin from microspheres presented two phases, initial burst release phase due to the protein adsorbed on the microsphere surface, followed by slower and continuous release phase corresponding to the protein entrapped in polymer matrix. The release rate was fairly constant after an initial burst release. Consequently, these microspheres can be proposed as new controlled release protein delivery system.

摘要

本研究的目的是研究微球作为蛋白质潜在药物载体的制备方法,用于控释制剂。选择亲水性牛血清白蛋白作为模型蛋白,采用水包油包水双乳液溶剂蒸发法将其包裹在聚(D,L-丙交酯-共-乙交酯)(50:50)微球中。研究了影响粒径、包封率和体外释放曲线的不同参数。在扫描电子显微镜下,用不同分子量和亲水性的聚(D,L-丙交酯-共-乙交酯)聚合物制备的微球无孔、表面光滑且呈球形结构,平均粒径范围为3.98至8.74μm。蛋白质负载效率为理论掺入量的40%至71%。牛血清白蛋白从微球中的体外释放曲线呈现两个阶段,由于蛋白质吸附在微球表面而导致的初始突释阶段,随后是对应于包裹在聚合物基质中的蛋白质的较慢且持续的释放阶段。在初始突释后,释放速率相当恒定。因此,这些微球可被提议作为新型控释蛋白质递送系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a6a/2792511/a0a664dfdf4a/IJPhS-70-303-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a6a/2792511/e3ee4c88c516/IJPhS-70-303-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a6a/2792511/ebc878f305b6/IJPhS-70-303-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a6a/2792511/a0a664dfdf4a/IJPhS-70-303-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a6a/2792511/e3ee4c88c516/IJPhS-70-303-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a6a/2792511/ebc878f305b6/IJPhS-70-303-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a6a/2792511/a0a664dfdf4a/IJPhS-70-303-g003.jpg

相似文献

1
Development and characterization of polymeric microspheres for controlled release protein loaded drug delivery system.用于控释载蛋白药物递送系统的聚合物微球的研制与表征
Indian J Pharm Sci. 2008 May-Jun;70(3):303-9. doi: 10.4103/0250-474X.42978.
2
Preparation, characterization and in vitro release study of BSA-loaded double-walled glucose-poly(lactide-co-glycolide) microspheres.载牛血清白蛋白的双层葡萄糖-聚(乳酸-共-乙醇酸)微球的制备、表征及体外释放研究。
Arch Pharm Res. 2016 Sep;39(9):1242-56. doi: 10.1007/s12272-016-0710-3. Epub 2016 Jan 27.
3
Preparation, characterization, and in vitro release studies of insulin-loaded double-walled poly(lactide-co-glycolide) microspheres.载胰岛素双壁聚(丙交酯-共-乙交酯)微球的制备、表征及体外释放研究
Drug Deliv Transl Res. 2016 Jun;6(3):308-18. doi: 10.1007/s13346-016-0278-y.
4
Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method.制备温度对采用复乳溶剂萃取/蒸发法制备的含蛋白质PLGA微球的特性及释放曲线的影响
J Control Release. 2000 Oct 3;69(1):81-96. doi: 10.1016/s0168-3659(00)00291-1.
5
Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.载胰岛素的 PLA-PEG 微球的制备、表征及体内评价用于控制型的肠外药物传递。
Drug Dev Ind Pharm. 2009 Nov;35(11):1364-74. doi: 10.3109/03639040902939213.
6
Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.丙交酯/乙交酯比例对更昔洛韦及其亲脂性前药(更昔洛韦单丁酸酯)从聚乳酸-羟基乙酸共聚物微球中的体外释放的影响。
Int J Pharm. 2007 Jun 29;338(1-2):133-41. doi: 10.1016/j.ijpharm.2007.01.038. Epub 2007 Feb 2.
7
Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.用于肠胃外缓释的高乌甲素微球:制剂变量的影响及体外特性研究
Pharmazie. 2011 Sep;66(9):654-61.
8
Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique.添加盐对采用W/O/W双乳液技术进行蛋白质微囊化的影响。
J Microencapsul. 2000 Jul-Aug;17(4):467-83. doi: 10.1080/026520400405723.
9
Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems.制剂变量对白蛋白从可生物降解微粒系统中的体外释放的影响。
J Microencapsul. 1997 May-Jun;14(3):349-56. doi: 10.3109/02652049709051138.
10
Biodegradable recombinant human erythropoietin loaded microspheres prepared from linear and star-branched block copolymers: influence of encapsulation technique and polymer composition on particle characteristics.由线性和星形嵌段共聚物制备的载有可生物降解重组人促红细胞生成素的微球:包封技术和聚合物组成对颗粒特性的影响。
J Control Release. 1999 Jun 2;59(3):309-25. doi: 10.1016/s0168-3659(99)00008-5.

引用本文的文献

1
Molecularly Imprinted Microspheres in Active Compound Separation from Natural Product.分子印迹微球在天然产物中活性化合物分离中的应用。
Molecules. 2024 Aug 26;29(17):4043. doi: 10.3390/molecules29174043.
2
Physiologically-Based Pharmacokinetic Modeling and In Vitro-In Vivo Correlation of TV-46000 (Risperidone LAI): Prediction from Dog to Human.基于生理的药代动力学建模及TV-46000(长效利培酮)的体外-体内相关性:从犬到人的预测
Pharmaceutics. 2024 Jul 4;16(7):896. doi: 10.3390/pharmaceutics16070896.
3
Development of a local controlled release system for therapeutic proteins in the treatment of skeletal muscle injuries and diseases.

本文引用的文献

1
Effect of additives on the release of a model protein from PLGA microspheres.添加剂对模型蛋白从聚乳酸-羟基乙酸共聚物微球中释放的影响。
AAPS PharmSciTech. 2001 Dec 17;2(4):30. doi: 10.1208/pt020430.
2
Biodegradable microspheres for protein delivery.用于蛋白质递送的可生物降解微球。
J Control Release. 2003 Jul 31;90(3):261-80. doi: 10.1016/s0168-3659(03)00194-9.
3
Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method.
开发局部控释系统治疗骨骼肌损伤和疾病的治疗性蛋白。
Cell Death Dis. 2024 Jul 2;15(7):470. doi: 10.1038/s41419-024-06645-2.
4
Gaussian processes modeling for the prediction of polymeric nanoparticle formulation design to enhance encapsulation efficiency and therapeutic efficacy.用于预测聚合物纳米颗粒制剂设计以提高包封效率和治疗效果的高斯过程建模
Drug Deliv Transl Res. 2025 Jan;15(1):372-388. doi: 10.1007/s13346-024-01625-7. Epub 2024 May 20.
5
Quality-by-Design Based Development of Doxycycline Hyclate-Loaded Polymeric Microspheres for Prolonged Drug Release.基于质量源于设计的载盐酸多西环素聚合物微球的开发,用于延长药物释放
AAPS PharmSciTech. 2024 Feb 29;25(3):49. doi: 10.1208/s12249-024-02760-7.
6
Mechanistic Computational Modeling of Implantable, Bioresorbable Drug Release Systems.植入式、可生物降解药物释放系统的机械计算建模。
Adv Mater. 2023 Dec;35(51):e2301698. doi: 10.1002/adma.202301698. Epub 2023 Sep 8.
7
Development of L-Lysine-Loaded PLGA Microparticles as a Controlled Release System for Angiogenesis Enhancement.负载L-赖氨酸的聚乳酸-羟基乙酸共聚物微粒作为促进血管生成的控释系统的研发
Pharmaceutics. 2023 Feb 1;15(2):479. doi: 10.3390/pharmaceutics15020479.
8
Human fetal mesenchymal stem cells secretome promotes scarless diabetic wound healing through heat-shock protein family.人胎儿间充质干细胞分泌组通过热休克蛋白家族促进无瘢痕糖尿病伤口愈合。
Bioeng Transl Med. 2022 Jun 21;8(1):e10354. doi: 10.1002/btm2.10354. eCollection 2023 Jan.
9
Surfactant Mediated Accelerated and Discriminatory In Vitro Drug Release Method for PLGA Nanoparticles of Poorly Water-Soluble Drug.用于难溶性药物PLGA纳米颗粒的表面活性剂介导的加速和区分性体外药物释放方法
Pharmaceuticals (Basel). 2022 Nov 29;15(12):1489. doi: 10.3390/ph15121489.
10
Comparison between Nanoparticle Encapsulation and Surface Loading for Lysosomal Enzyme Replacement Therapy.用于溶酶体酶替代疗法的纳米颗粒包封与表面负载的比较。
Int J Mol Sci. 2022 Apr 6;23(7):4034. doi: 10.3390/ijms23074034.
采用复乳溶剂萃取/蒸发法制备的含蛋白质可生物降解聚合物微球的形态、药物分布及体外释放曲线
Biomaterials. 2001 Feb;22(3):231-41. doi: 10.1016/s0142-9612(00)00178-2.
4
Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres.聚合物与微球共混以改变肽从聚乳酸-羟基乙酸共聚物微球中的释放。
Eur J Pharm Biopharm. 2000 Sep;50(2):263-70. doi: 10.1016/s0939-6411(00)00099-0.
5
Preparation of microspheres by the solvent evaporation technique.通过溶剂蒸发技术制备微球。
Adv Drug Deliv Rev. 1997 Oct 13;28(1):25-42. doi: 10.1016/s0169-409x(97)00049-5.
6
Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.蛋白质从聚(丙交酯-共-乙交酯)微球中的包封与释放:蛋白质和聚合物性质以及表面活性剂共包封的影响
Eur J Pharm Biopharm. 1998 May;45(3):285-94. doi: 10.1016/s0939-6411(98)00011-3.
7
Biodegradable microspheres in drug delivery.药物递送中的可生物降解微球。
Crit Rev Ther Drug Carrier Syst. 1995;12(1):1-99. doi: 10.1615/critrevtherdrugcarriersyst.v12.i1.10.
8
Implantable drug delivery.可植入式药物递送
J Biomater Appl. 1994 Jan;8(3):247-84. doi: 10.1177/088532829400800305.
9
Drug delivery systems and routes of administration of peptide and protein drugs.肽类和蛋白质药物的给药系统及给药途径
Eur J Drug Metab Pharmacokinet. 1990 Apr-Jun;15(2):95-102. doi: 10.1007/BF03190192.